IMU 9.26% 5.9¢ imugene limited

Linkedin Bio for Kim Drapkin - Currently, I am seeking board of...

  1. 19 Posts.
    lightbulb Created with Sketch. 33
    Linkedin Bio for Kim Drapkin -

    Currently, I am seeking board of director roles in the biotechnology sector. A qualified NASDAQ financial expert and experienced Chief Financial Officer, I have served as the audit chair of multiple public companies. Having also served on board transaction, compensation and audit committees,

    I bring more than 30 years of experience working with private and publicly traded biotechnology and pharmaceutical companies, including:building and leading finance functionsraising capitalleading strategic financial planning.significant IPO, fund raising, merger and operational experience I have had the honor of having served on several public board of directors including:

    Acumen (NASDAQ:ABIOS): Audit chair and compensation committee
    2021-present Yumanity Therapeutics (NASDAQ: YMTX) Audit, compensation and transaction committees
    2020-2022Proteostasis Therapeutics (NASDAQ: PTI)
    2019-2020, chair of the audit committee, member of the governance, transaction and compensation committees.

    In addition, I have also served as a Trustee to an independent school and am currently a member of the Dana-Farber Cancer Institute Patient and Family Advisory Council.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.9¢
Change
0.005(9.26%)
Mkt cap ! $433.6M
Open High Low Value Volume
5.5¢ 5.9¢ 5.4¢ $1.489M 25.99M

Buyers (Bids)

No. Vol. Price($)
2 35252 5.9¢
 

Sellers (Offers)

Price($) Vol. No.
6.0¢ 1753430 24
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.